InsidersTradesSigma
Explore the full record of transactions filed by Buten Matthew. Director active across 1 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. Cumulatively, 2 disclosures have been recorded. The latest transaction was filed on 31 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations